The tested sample of Tabex 1.5 mg, film-coated tablets, batch No. 31120, does not meet specification requirements for impurity content (N-formylcitisine level). Potential effects: possible adverse reactions, poisoning, lack of expected therapeutic efficacy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Tabex tablets from batch 31120. Check the batch number on the packaging and return the product to a pharmacy or consult a doctor or pharmacist for further guidance.
The Chief Pharmaceutical Inspector withdrew batch 31120 of Tabex 1.5 mg, film-coated tablets from the market throughout the country and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related